Y-mAbs Therapeutics, Inc.
NASDAQ:YMAB
13.74 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 84.819 | 65.267 | 34.897 | 20.75 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 11.416 | 7.567 | 2.514 | 2.203 | 0.166 | 0.029 | 0 | 0 |
| Gross Profit
| 73.403 | 57.7 | 32.383 | 18.547 | -0.166 | -0.029 | 0 | 0 |
| Gross Profit Ratio
| 0.865 | 0.884 | 0.928 | 0.894 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 50.873 | 91.572 | 93.245 | 93.697 | 63.492 | 34.269 | 14.307 | 13.855 |
| General & Administrative Expenses
| 0 | 0 | 0 | 44.785 | 19.512 | 8.961 | 4.937 | 3.184 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 43.72 | 60.939 | 54.571 | 44.785 | 19.512 | 8.961 | 4.937 | 3.184 |
| Other Expenses
| 0 | 0 | 62.01 | -2.203 | 0 | -0.044 | 0.083 | -0.018 |
| Operating Expenses
| 94.593 | 152.511 | 147.816 | 138.482 | 83.004 | 43.23 | 19.244 | 17.039 |
| Operating Income
| -21.19 | -94.811 | -115.433 | -119.935 | -83.004 | -43.23 | -19.244 | -17.039 |
| Operating Income Ratio
| -0.25 | -1.453 | -3.308 | -5.78 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.324 | -0.757 | 60.158 | 0.598 | 1.976 | -0.044 | 0.083 | -0.018 |
| Income Before Tax
| -20.866 | -95.568 | -55.275 | -119.337 | -81.028 | -43.274 | -19.161 | -17.057 |
| Income Before Tax Ratio
| -0.246 | -1.464 | -1.584 | -5.751 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.561 | 0.757 | 1.07 | -0.994 | -2.142 | -0.044 | -19.244 | -17.039 |
| Net Income
| -21.427 | -96.325 | -56.345 | -118.343 | -78.886 | -43.274 | -19.161 | -17.057 |
| Net Income Ratio
| -0.253 | -1.476 | -1.615 | -5.703 | 0 | 0 | 0 | 0 |
| EPS
| -0.49 | -2.2 | -1.3 | -2.95 | -2.24 | -1.5 | -0.58 | -0.51 |
| EPS Diluted
| -0.49 | -2.2 | -1.3 | -2.95 | -2.24 | -1.5 | -0.58 | -0.51 |
| EBITDA
| -20.455 | -94.811 | -115.433 | -117.732 | -83.004 | -43.23 | -19.244 | -17.039 |
| EBITDA Ratio
| -0.241 | -1.453 | -3.308 | -5.674 | 0 | 0 | 0 | 0 |